These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4588772)

  • 21. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL; Chu LW; Peiris JS; Chan KH; Chu D; Tsui W
    Vaccine; 2006 Jun; 24(25):5371-80. PubMed ID: 16713661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the antibody status of a population following epidemic infection by influenza virus A2-Hong Kong-1-68.
    Machin SJ; Potter CW; Oxford JS
    J Hyg (Lond); 1970 Sep; 68(3):497-504. PubMed ID: 5272348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled trial of inactivated monovalent influenza A vaccines in general practice.
    Mair HJ; Sansome DA; Tillett HE
    J Hyg (Lond); 1974 Oct; 73(2):317-27. PubMed ID: 4608708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response.
    Pereira MS; Chakraverty P; Schild GC; Coleman MT; Dowdle WR
    Br Med J; 1972 Dec; 4(5842):701-3. PubMed ID: 4646846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interim estimates of the effectiveness of influenza vaccination against influenza-associated hospitalization in children in Hong Kong, 2015-16.
    Cowling BJ; Kwan MY; Wong JS; Feng S; Leung CW; Chan EL; Chan KH; Ng TK; To WK; Peiris MJ; Chiu SS
    Influenza Other Respir Viruses; 2017 Jan; 11(1):61-65. PubMed ID: 27313064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant influenza-A viruses as live vaccines for man. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines.
    Beare AS; Hall TS
    Lancet; 1971 Dec; 2(7737):1271-3. PubMed ID: 4143531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial Protection Induced by 2011-2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People.
    Camilloni B; Basileo M; Menculini G; Tozzi P; Iorio AM
    Adv Exp Med Biol; 2016; 897():45-53. PubMed ID: 26577530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative trials of live attenuated and detergent split influenza virus vaccines.
    Mackenzie JS; Mackenzie I; Lloyd J; Dent V
    J Hyg (Lond); 1975 Dec; 75(3):425-43. PubMed ID: 1059709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines.
    Slepushkin AN; Schild GC; Beare AS; Chinn S; Tyrrell DA
    J Hyg (Lond); 1971 Dec; 69(4):571-8. PubMed ID: 5002644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children.
    Gross PA; Ennis FA; Gaerlan PF; Denson LJ; Denning CR; Schiffman D
    J Infect Dis; 1977 Nov; 136(5):623-32. PubMed ID: 335000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field trial with human and equine influenza vaccines in children: protection and antibody titres.
    Wesselius-de Casparis A; Masurel N; Kerrebijn KF
    Bull World Health Organ; 1972; 46(2):151-7. PubMed ID: 4555773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.
    Cowling BJ; Ng S; Ma ES; Cheng CK; Wai W; Fang VJ; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
    Clin Infect Dis; 2010 Dec; 51(12):1370-9. PubMed ID: 21067351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A/USSR and B/Hong Kong vaccine. Field experiences during an A/Brazil and an influenza B epidemic.
    Foy HM; Allan I; Blumhagen JM; Cooney MK; Hall C; Fox JP
    JAMA; 1981 May; 245(17):1736-40. PubMed ID: 6163876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
    Nicholson KG; Colegate AE; Podda A; Stephenson I; Wood J; Ypma E; Zambon MC
    Lancet; 2001 Jun; 357(9272):1937-43. PubMed ID: 11425416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dosage and route of inoculation upon antigenicity of inactivated influenza virus vaccine (Hong Kong strain) in man.
    Tauraso NM; Gleckman R; Pedreira FA; Sabbaj J; Yahwak R; Madoff MA
    Bull World Health Organ; 1969; 41(3):507-16. PubMed ID: 5309465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.